SERPINE1 and metabolic dysfunction-associated steatotic liver disease: A meta-analysis of 10,540 multiracial subjects found a significant association between serum PAI-1 levels and biopsy-proven or CT-diagnosed nonalcoholic fatty liver disease (NAFLD) [37].